Research progress on radiotherapy combined with chemotherapy for locally advanced nasopharyngeal carcinoma

VernacularTitle:局部晚期鼻咽癌放疗与化疗联合治疗进展
Author: Yanling WU ¹ ; Yupei CHEN ; Jun MA
Author Information

1. 中山大学肿瘤防治中心放疗科　华南肿瘤学国家重点实验室肿瘤医学协同创新中心　广东省鼻咽癌诊治研究重点实验室，广州　510060
Keywords: Nasopharyngeal neoplasm/concurrent chemoradiotherapy; Nasopharyngeal neoplasm/induction chemotherapy; Nasopharyngeal neoplasm/adjuvant chemotherapy; Rese
From: Chinese Journal of Radiation Oncology 2021;30(10):1084-1088
CountryChina
Language:Chinese
Abstract: Nasopharyngeal carcinoma (NPC) is one of the common head and neck malignant tumors. Radiotherapy is the main treatment for NPC. The comprehensive application of chemotherapy strategies (induction, concurrent and adjuvant) in radiotherapy has improved the efficacy in the treatment of locally advanced NPC. Based on current evidence, concurrent chemoradiotherapy combined with adjuvant or induction chemotherapy has been recommended as the standard treatment for locally advanced NPC. However, there are still many deficiencies in the standard treatment, and the application of induction and adjuvant chemotherapy remains controversial. Establishing a more ideal and individualized chemoradiotherapy for locally advanced NPC is still the research direction in the future.